V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330002463 | 330001366 | 1.67 | 53 | Palliative (P) | 2013-07-11 | 2013-07-18 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330009158 | CARBOPLATIN + PACLITAXEL |
| 330002464 | 330001367 | null | 63.3 | Palliative (P) | 2017-12-13 | 2017-12-14 | Carboplatin + Paclitaxel (3 weekly) | N | null | 330009160 | CARBOPLATIN + PACLITAXEL |
| 330002465 | 330006719 | 1.67 | 83.1 | Palliative (P) | null | 2016-09-10 | CARBOPLATIN + PACLITAXEL | N | N | 330009161 | CARBOPLATIN + PACLITAXEL |
| 330002466 | 330001368 | 1.69 | 73.7 | Curative (C) | 2016-08-16 | 2016-09-03 | CARBOPLATIN + ETOPOSIDE | N | N | 330009166 | CARBOPLATIN + ETOPOSIDE |
| 330002467 | 330001369 | 1.51 | 79.2 | Curative (C) | 2015-08-12 | 2015-08-17 | BENDAMUSTINE + RITUXIMAB | N | N | 330009169 | BENDAMUSTINE + RITUXIMAB |
| 330002468 | 330001370 | 1.48 | 64 | null | 2014-02-08 | 2014-02-11 | Rituximab | N | N | 330009174 | RITUXIMAB |
| 330002469 | 330001371 | 1.8 | 79.3 | Disease modification (D) | 2015-06-22 | 2015-06-30 | BENDAMUSTINE + RITUXIMAB | 2 | N | 330009183 | BENDAMUSTINE + RITUXIMAB |
| 330002470 | 330006720 | null | 91.4 | Curative (C) | null | 2016-06-05 | CARBOPLATIN + ETOPOSIDE | N | N | 330009184 | CARBOPLATIN + ETOPOSIDE |
| 330002471 | 330001372 | null | 70 | Neo-adjuvant (N) | 2015-08-29 | 2015-09-02 | Carboplatin AUC 6 - 10 | 02 | N | 330009189 | CARBOPLATIN |
| 330002472 | 330001373 | 1.59 | 56 | Curative (C) | 2013-02-14 | 2013-04-09 | Rituximab | 2 | N | 330009190 | RITUXIMAB |
| 330002473 | 330006721 | 1.59 | 72.9 | Curative (C) | 2013-05-28 | 2013-06-01 | Carboplatin AUC 2 - 5 | N | N | 330009194 | CARBOPLATIN |
| 330002474 | 330006721 | 1.57 | 111 | Palliative (P) | 2014-07-15 | 2014-07-15 | Bendamustine+Rituximab (1st Course) | null | N | 330009194 | BENDAMUSTINE + RITUXIMAB |
| 330002475 | 330001374 | 1.71 | null | Palliative (P) | 2016-07-15 | 2016-07-31 | Doxorubicin 75mg/m2 | 02 | N | 330009199 | DOXORUBICIN |
| 330002476 | 330001374 | 1.78 | 78.8 | Curative (C) | 2014-11-05 | 2014-12-02 | Cisplatin + Doxorubicin | N | N | 330009199 | CISPLATIN + DOXORUBICIN |
| 330002477 | 330001374 | 1.8 | 89 | Not known (9) | 2016-03-06 | 2016-03-20 | BENDAMUSTINE + RITUXIMAB | 2 | null | 330009199 | BENDAMUSTINE + RITUXIMAB |
| 330002479 | 330001376 | 1.76 | 72.3 | Palliative (P) | 2015-05-02 | 2015-05-19 | Liposomal Doxorubicin 40mg/m2 | 02 | N | 330009210 | LIPOSOMAL DOXORUBICIN |
| 330002480 | 330001376 | 1.77 | 73.7 | Neo-adjuvant (N) | 2015-09-28 | 2015-11-08 | CARBOPLATIN + PACLITAXEL | 2 | Y | 330009210 | CARBOPLATIN + PACLITAXEL |
| 330002481 | 330001376 | null | 97.4 | Palliative (P) | 2013-05-05 | 2013-05-09 | BENDAMUSTINE + RITUXIMAB | N | N | 330009210 | BENDAMUSTINE + RITUXIMAB |
| 330002482 | 330001376 | 1.47 | 88.9 | null | 2015-09-12 | 2015-09-18 | Cisplatin + Doxorubicin | N | N | 330009210 | CISPLATIN + DOXORUBICIN |
| 330002483 | 330001377 | 1.74 | null | Palliative (P) | 2015-04-02 | 2015-04-02 | Cisplatin + Doxorubicin | N | N | 330009226 | CISPLATIN + DOXORUBICIN |
| 330002484 | 330001378 | null | 59.5 | Disease modification (D) | 2016-06-03 | 2016-06-08 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 330009240 | BENDAMUSTINE + RITUXIMAB |
| 330002485 | 330001378 | 1.71 | 79.3 | Curative (C) | null | 2017-06-12 | Rituximab | N | N | 330009240 | RITUXIMAB |
| 330002486 | 330001378 | 1.57 | null | Curative (C) | 2013-04-19 | 2013-04-19 | Liposomal Doxorubicin (20mg/m2) | N | N | 330009240 | LIPOSOMAL DOXORUBICIN |
| 330002487 | 330001378 | 1.65 | 53 | Palliative (P) | null | 2017-01-20 | Cisplatin + Doxorubicin | N | N | 330009240 | CISPLATIN + DOXORUBICIN |
| 330002488 | 330001379 | 1.62 | 79.6 | Neo-adjuvant (N) | null | 2016-06-07 | CNS GCT II Germinoma - Carbo Etop | N | N | 330009250 | CARBOPLATIN + ETOPOSIDE |
| 330002489 | 330001380 | 1.7 | 89.5 | Palliative (P) | 2015-08-15 | 2015-08-24 | BENDAMUSTINE + RITUXIMAB | N | N | 330009251 | BENDAMUSTINE + RITUXIMAB |
| 330002490 | 330001380 | 1.68 | 87 | Neo-adjuvant (N) | 2013-02-09 | 2013-02-10 | Cisplatin + Doxorubicin | 2 | null | 330009251 | CISPLATIN + DOXORUBICIN |
| 330002494 | 330001381 | 1.78 | 50.2 | Disease modification (D) | 2015-09-05 | 2015-09-17 | Liposomal Doxorubicin (Caelyx) | N | N | 330009266 | LIPOSOMAL DOXORUBICIN |
| 330002495 | 330001382 | 1.78 | null | Palliative (P) | 2013-09-12 | 2013-09-23 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330009267 | CARBOPLATIN + PACLITAXEL |
| 330002496 | 330001382 | 1.85 | 108.2 | Neo-adjuvant (N) | 2013-07-17 | 2013-07-24 | CNS GCT II Germinoma - Carbo Etop | N | N | 330009267 | CARBOPLATIN + ETOPOSIDE |
| 330002497 | 330001382 | 1.6 | 57.1 | Curative (C) | 2014-02-09 | 2014-02-18 | Rituximab | 02 | N | 330009267 | RITUXIMAB |
| 330002498 | 330001382 | 1.52 | 75 | Disease modification (D) | 2016-02-19 | 2016-03-04 | Bendamustine+Rituximab (1st Course) | 2 | N | 330009267 | BENDAMUSTINE + RITUXIMAB |
| 330002499 | 330001382 | 1.69 | 94.8 | Palliative (P) | 2014-06-04 | 2014-06-04 | CARBOPLATIN + ETOPOSIDE | 2 | N | 330009267 | CARBOPLATIN + ETOPOSIDE |
| 330002500 | 330001383 | 1.54 | 98 | Palliative (P) | null | 2014-03-27 | Cisplatin + Doxorubicin | N | N | 330009285 | CISPLATIN + DOXORUBICIN |
| 330002507 | 330001387 | 1.6 | 77.8 | Palliative (P) | 2014-01-05 | 2014-01-05 | Rituximab | 02 | N | 330009303 | RITUXIMAB |
| 330002508 | 330001387 | 1.75 | 77 | Palliative (P) | null | 2017-10-22 | Cisplatin + Doxorubicin | N | N | 330009303 | CISPLATIN + DOXORUBICIN |
| 330002509 | 330001388 | 1.8 | null | Neo-adjuvant (N) | 2016-09-27 | 2016-10-06 | Cisplatin + Doxorubicin | N | N | 330009306 | CISPLATIN + DOXORUBICIN |
| 330002510 | 330001388 | 1.82 | null | Palliative (P) | 2014-07-23 | 2014-08-05 | Rituximab (Maintenance) | 02 | N | 330009306 | RITUXIMAB |
| 330002511 | 330001389 | 1.62 | 62.8 | Palliative (P) | 2013-11-13 | 2013-11-13 | Bendamustine+Rituximab(Sub Courses) | 02 | N | 330009311 | BENDAMUSTINE + RITUXIMAB |
| 330002512 | 330001389 | 1.61 | 58.2 | null | null | 2014-10-23 | Rituximab | N | N | 330009311 | RITUXIMAB |
| 330002513 | 330001389 | 1.63 | 78.6 | Disease modification (D) | null | 2015-07-08 | Rituximab | null | null | 330009311 | RITUXIMAB |
| 330002514 | 330001389 | null | 107 | Palliative (P) | 2017-06-20 | 2017-07-11 | Carboplatin + Paclitaxel (weekly) | N | N | 330009311 | CARBOPLATIN + PACLITAXEL |
| 330002515 | 330001389 | 1.82 | 68.4 | Palliative (P) | 2015-03-29 | 2015-04-14 | Doxorubicin 75mg/m2 | N | N | 330009311 | DOXORUBICIN |
| 330002516 | 330001389 | null | 65.8 | Adjuvant (A) | null | 2016-08-13 | Carboplatin + Paclitaxel (3 weekly) | null | null | 330009311 | CARBOPLATIN + PACLITAXEL |
| 330002517 | 330012922 | 1.58 | 47.3 | null | 2014-09-25 | 2014-09-28 | Cisplatin + Doxorubicin | N | N | 330009333 | CISPLATIN + DOXORUBICIN |
| 330002518 | 330001390 | 1.83 | 72.9 | Palliative (P) | 2015-12-18 | 2015-12-25 | Doxorubicin 75mg/m2 | null | N | 330009341 | DOXORUBICIN |
| 330002519 | 330006731 | 1.5 | 57 | Curative (C) | 2016-05-10 | 2016-05-10 | CNS GCT II Germinoma - Carbo Etop | N | N | 330009342 | CARBOPLATIN + ETOPOSIDE |
| 330002520 | 330006731 | 1.65 | 61.3 | Palliative (P) | 2014-05-31 | 2014-06-15 | CARBOPLATIN + PACLITAXEL | 02 | N | 330009342 | CARBOPLATIN + PACLITAXEL |
| 330002521 | 330001391 | 1.73 | null | Palliative (P) | null | 2013-08-05 | Bendamustine+Rituximab(Sub Courses) | N | N | 330009345 | BENDAMUSTINE + RITUXIMAB |
| 330002525 | 330001393 | 1.68 | 106 | Disease modification (D) | 2016-10-05 | 2016-10-20 | Bendamustine+Rituximab (1st Course) | 02 | Y | 330009370 | BENDAMUSTINE + RITUXIMAB |